$DOGP

Dogecoin Cash, Inc.

Dogecoin Cash operates primarily through its majority-owned subsidiary PrestoCorp, Inc., which does business as PrestoDoctor. The platform connects patients with licensed physicians for medical cannabis evaluations through secure remote video consultations where permitted by state law. Dogecoin Cash provides the technology platform and administrative support; independent physicians are responsible for the medical services they provide. The company generates substantially all of its revenue from telemedicine consultation services facilitated through PrestoDoctor and operates without owning physical clinics or healthcare facilities. Dogecoin Cash also holds cannabis-related intellectual property through Kubby Patent and Licenses, LLC, including a plant patent and a patent relating to a cannabinoid-containing lozenge delivery system. Its subsidiaries include entities for digital asset and technology initiatives, which are ancillary to its principal telemedicine operations. Dogecoin Cash maintains its principal executive office in Mesquite, Nevada.

0
1
0

No SEC Form 4 filings for $DOGP in the last 30 days.

See all $DOGP insider activity →
Med

Dogecoin Cash 3Q 2026: Revenue $164.42K, EPS $0 — 10-Q Summary

Dogecoin Cash reported a 14% revenue decline to $164.42K in Q3 2026, citing competitive pressure in cannabis telemedicine. EPS was $0. Operating expenses fell 26% to $200.31K. The company had $9.49K in cash and used $24.1K in operating activities. According to the company, unrealized investment gains and convertible loan value changes contributed to other income.

Dogecoin Cash CEO reports 125,000-share trade

Dogecoin Cash, Inc. (CBDS) CEO David Tobias reported a trade of 125,000 shares at $0.008 per share, according to an SEC Form 4 filing. Tobias is also a director and 10% owner of the company.

DOGP sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning DOGP (Dogecoin Cash, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent DOGP coverage spans earnings, insider activity and financial news.

What's driving DOGP

  • Lower revenue but improved bottom-line profitability, with gains from investments and convertible-loan fair value changes supporting earnings.

    tradingview.com · Nov 20, 2026

  • The insider purchase is modest but signals confidence from the CEO.

    SEC EDGAR · Sep 28, 2026

  • Dogecoin Cash, Inc. (CBDS) CEO David Tobias reported a trade of 125,000 shares at $0.008 per share, according to an SEC Form 4 filing. Tobias is also a director and 10% owner of the company.

    stocktitan.net · Sep 28, 2026

AlphAI scores every news story that mentions DOGP with an AI model for sentiment and relevance, and aggregates insider trades from Dogecoin Cash, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $DOGP

Score

Dogecoin Cash 3Q 2026: Revenue $164.42K, EPS $0 — 10-Q Summary

Dogecoin Cash reported a 14% revenue decline to $164.42K in Q3 2026, citing competitive pressure in cannabis telemedicine. EPS was $0. Operating expenses fell 26% to $200.31K. The company had $9.49K in cash and used $24.1K in operating activities. According to the company, unrealized investment gains and convertible loan value changes contributed to other income.

Related tickers